← FDA Drug Approvals (Drugs@FDA)

ATROPINE SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEDEFIL INC · Approved 2022-11-04

Drug application

FDA Application #

ANDA214970

Application type

Abbreviated New Drug Application (Generic)

Brand name

ATROPINE SULFATE

Generic name

ATROPINE SULFATE INJECTION

Active ingredients

ATROPINE SULFATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

MEDEFIL INC

Manufacturer

Medefil, Inc.

First approval

2022-11-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown